News
News
- MediciNova Announces MN-166 (ibudilast) Identified as Promising Pharmacotherapy for Alcohol Use Disorder in Drugs
02/22/2022 / 12:30 - GlobeNewswire - Thunderstruck Announces Strategic Investment by Australian Mining Entrepreneur
02/14/2022 / 21:14 - Newsfile Corp - ALX Resources Corp. Closes Athabasca Basin Properties Transaction with Okapi Resources Ltd
02/01/2022 / 14:35 - Newsfile Corp - Adial Pharmaceuticals Announces Private Placement of Common Stock at $4.00 Per Share and Cash Exercise of Stock Options
11/10/2021 / 15:26 - GlobeNewswire - ALX Resources Corp. Sells Six Athabasca Basin Properties to Okapi Resources
11/09/2021 / 13:30 - Newsfile Corp - International Lithium Corp. Expands Raleigh Lake Lithium and Rubidium project in Ontario, Canada and divests its 49% interest in Mavis Lake Lithium Project, Canada
10/25/2021 / 10:00 - Newsfile Corp - Claritas Announces Proposed Financing with Obsidian Global GP, LLC, Receipt of Australian Tax Credit, and Start of Phase 1 Clinical Study of R-107
08/18/2021 / 18:52 - GlobeNewswire - UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021
07/22/2021 / 15:00 - GlobeNewswire - MediciNova Announces Positive Results from Phase 2 Trial of MN-166 (ibudilast) in Alcohol Use Disorder Published in Nature’s Translational Psychiatry Journal
06/21/2021 / 12:30 - GlobeNewswire - Novo Completes Malmsbury Option Exercise with GBM Resources Limited
05/13/2021 / 14:30 - GlobeNewswire
Real-time